Structural biology spin-out tackles major diseases
Thursday, August 7, 2008 - 10:07
in Biology & Nature
A spin out company from basic structural biology, Asterion Ltd., has led to new technology that provides a way of creating therapeutic proteins to tackle major diseases such as cancer, diabetes and infertility. The research was carried out at the University of Sheffield in laboratories supported by the Biotechnology and Biological Sciences Research Council (BBSRC). This work is reported in the current edition of BBSRC Business, the quarterly research highlights magazine of the Biotechnology and Biological Sciences Research Council.
Read the whole article on Physorg
More from Physorg
Related
- Structural biology spin-out tackles major diseasesThu, 7 Aug 2008, 11:08:33 EDT
- Insight into fish disease to help protect farmed fish stocksThu, 23 Apr 2009, 19:30:06 EDT
- 'Spaghetti' scaffolding could help grow skin in labsFri, 16 Oct 2009, 10:50:50 EDT
- Synthetic Biology: funders move to address social and ethical challengesSun, 8 Jun 2008, 22:21:28 EDT
- Maintaining the brain's wiring in aging and diseaseFri, 5 Dec 2008, 12:19:40 EST